Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
GLP-1 medications (semaglutide, tirzepatide): FDA-approved for chronic weight management and type 2 diabetes
Among firms offering health benefits, 42% of small firms and 69% of large firms offer programs to help workers stop smoking or using tobacco, 44% of small firms and 63% of large firms offer programs to help workers lose weight, and 48% of small firms and 71% of large firms offer some other lifestyle or behavioral coaching program
Higher doses don't necessarily produce proportionally better results
.png)
Our Health Coaches can help assess your current diet and suggest changes that are suited to your goals and lifestyle
These should comprise a smaller portion of your meals compared to lean proteins and non-starchy vegetables
Use of SYNJARDY for this indication is supported by evidence from a 26-week double-blind, placebo-controlled clinical trial of empagliflozin, with a double-blind active treatment safety extension period of up to 52 weeks in 157 pediatric patients aged 10 to 17 years with type 2 diabetes mellitus and a pediatric pharmacokinetic study [see Clinical Pharmacology (12.3) and Clinical Studies (14.2)]
